cancerantibodies.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.cancerantibodies.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Cancer Antibodies - Discovering Unique Surface Antigens on Cancer |
| Description | Discovering New Treatment Targets on Cancer Cancer Antibodies Inc. is focused on using novel methods to identify unique antigenic sites on the surface of cancer |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 108.179.242.234 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cancerantibodies.com Valuation
|
US$455,027
Last updated: 2023-05-18 01:48:58
cancerantibodies.com has Semrush global rank of 23,260,869. cancerantibodies.com has an estimated worth of US$ 455,027, based on its estimated Ads revenue. cancerantibodies.com receives approximately 52,504 unique visitors each day. Its web server is located in United States, with IP address 108.179.242.234. According to SiteAdvisor, cancerantibodies.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$455,027 |
| Daily Ads Revenue | US$421 |
| Monthly Ads Revenue | US$12,601 |
| Yearly Ads Revenue | US$151,209 |
| Daily Unique Visitors | 3,501 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cancerantibodies.com. | A | 14400 | IP: 108.179.242.234 |
| cancerantibodies.com. | NS | 86400 | NS Record: cns113.hostgator.com. |
| cancerantibodies.com. | NS | 86400 | NS Record: cns114.hostgator.com. |
| cancerantibodies.com. | MX | 14400 | MX Record: 10 alt3.aspmx.l.google.com. |
| cancerantibodies.com. | MX | 14400 | MX Record: 10 alt4.aspmx.l.google.com. |
| cancerantibodies.com. | MX | 14400 | MX Record: 1 aspmx.l.google.com. |
| cancerantibodies.com. | MX | 14400 | MX Record: 5 alt1.aspmx.l.google.com. |
| cancerantibodies.com. | MX | 14400 | MX Record: 5 alt2.aspmx.l.google.com. |
| cancerantibodies.com. | TXT | 14400 | TXT Record: v=spf1 include:_spf.google.com ~all |
| cancerantibodies.com. | TXT | 14400 | TXT Record: google-site-verification=1VUdUSrzpF8tgR4kUjOTniHIXOPHaFxjmuSoMAGsV20 |
| cancerantibodies.com. | TXT | 14400 | TXT Record: google-site-verification=ZXBQw0i6uIqbi7-8bjXLJdyyKq9KXO18eY2Wl0HIs8E |
| cancerantibodies.com. | TXT | 14400 | TXT Record: google-site-verification=HQHNdAw2eB4RWATYlyxn2-QI-lW2BXWwNUvzmeRhZZg |
HtmlToTextCheckTime:2023-05-18 01:48:58
| Toggle navigation Home ASCO Publication, Poster & Video Poster Publication Video Presentation About Partner Press Contact Donate Discovering New Treatment Targets on Cancer Cells Offering Solutions to the Biggest Challenges in Cancer Treatment Today VIDEO PRESENTATION POSTER PUBLICATION Cancer Antibodies Inc is a 501(c)(3) non-profit organization. Donations are tax-deductible as allowed by U.S. law. Support This Breakthrough DISCOVERY We have achieved a breakthrough in the struggle to differentiate between normal and cancer cells. Using a novel method, we have developed a platform that identifies unique targets (neoantigens) on the surface of cancer cells and not normal cells . When those unique sites are targeted, cancer cells can be preferentially killed while leaving nearby normal cells unharmed. The method can be applied to any type of cancer. We are looking for partners & collaborators to help carry this research to the clinic and start saving lives. The results of a study using |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 05 May 2022 09:08:24 GMT Server: Apache X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://cancerantibodies.com/ Vary: User-Agent Content-Type: text/html; charset=UTF-8 HTTP/2 301 x-redirect-by: WordPress location: https://www.cancerantibodies.com/ vary: User-Agent content-type: text/html; charset=UTF-8 date: Thu, 05 May 2022 09:08:27 GMT server: Apache HTTP/2 200 vary: User-Agent,Accept-Encoding last-modified: Thu, 05 May 2022 05:59:48 GMT accept-ranges: bytes content-length: 47406 cache-control: max-age=0, no-cache, no-store, must-revalidate pragma: no-cache expires: Mon, 29 Oct 1923 20:30:00 GMT content-type: text/html; charset=UTF-8 date: Thu, 05 May 2022 09:08:28 GMT server: Apache |
cancerantibodies.com Whois Information
Domain Name: CANCERANTIBODIES.COM Registry Domain ID: 2143088657_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-15T13:08:46Z Creation Date: 2017-07-14T16:01:37Z Registry Expiry Date: 2022-07-14T16:01:37Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: CNS113.HOSTGATOR.COM Name Server: CNS114.HOSTGATOR.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-05T10:43:52Z <<< |